Item 1. Description of Registrants Securities to be Registered.
The description of the Common Stock, par value $0.001 per share, of Proteon Therapeutics, Inc. (the Registrant) as included under the caption Description of Capital Stock in the Registrants Registration Statement on Form S-1, as amended, originally filed with the Securities and Exchange Commission (the Commission) on September 16, 2014 (Registration No. 333-198777), including exhibits, and as may be subsequently amended from time to time (the Registration Statement), is hereby incorporated by reference. In addition, all of the above-referenced descriptions included in any prospectus relating to the Registration Statement filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.
Item 2. Exhibits.
Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Exchange Act